These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17202346)

  • 1. Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis.
    Bullard DC; Hu X; Schoeb TR; Collins RG; Beaudet AL; Barnum SR
    J Immunol; 2007 Jan; 178(2):851-7. PubMed ID: 17202346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of both ICAM-1 and C3 enhances severity of experimental autoimmune encephalomyelitis compared to C3-deficient mice.
    Smith SS; Ludwig M; Wohler JE; Bullard DC; Szalai AJ; Barnum SR
    Neurosci Lett; 2008 Sep; 442(2):158-60. PubMed ID: 18634851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.
    Eugster HP; Frei K; Kopf M; Lassmann H; Fontana A
    Eur J Immunol; 1998 Jul; 28(7):2178-87. PubMed ID: 9692887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis.
    Bullard DC; Hu X; Schoeb TR; Axtell RC; Raman C; Barnum SR
    J Immunol; 2005 Nov; 175(10):6327-33. PubMed ID: 16272284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential ICAM-1 isoform expression regulates the development and progression of experimental autoimmune encephalomyelitis.
    Hu X; Barnum SR; Wohler JE; Schoeb TR; Bullard DC
    Mol Immunol; 2010 May; 47(9):1692-1700. PubMed ID: 20371120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis.
    Bullard DC; Hu X; Adams JE; Schoeb TR; Barnum SR
    Am J Pathol; 2007 Jun; 170(6):2001-8. PubMed ID: 17525267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a single ICAM-1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitis.
    Bullard DC; Hu X; Crawford D; McDonald K; Ramos TN; Barnum SR
    Eur J Immunol; 2014 Apr; 44(4):1194-9. PubMed ID: 24435747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis.
    Chaudhary P; Marracci GH; Bourdette DN
    J Neuroimmunol; 2006 Jun; 175(1-2):87-96. PubMed ID: 16644024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental autoimmune encephalomyelitis in intercellular adhesion molecule-1-deficient mice.
    Samoilova EB; Horton JL; Chen Y
    Cell Immunol; 1998 Nov; 190(1):83-9. PubMed ID: 9826450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis.
    Muramatsu R; Kubo T; Mori M; Nakamura Y; Fujita Y; Akutsu T; Okuno T; Taniguchi J; Kumanogoh A; Yoshida M; Mochizuki H; Kuwabara S; Yamashita T
    Nat Med; 2011 Apr; 17(4):488-94. PubMed ID: 21423182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.
    Matsushita T; Fujimoto M; Hasegawa M; Komura K; Takehara K; Tedder TF; Sato S
    Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic susceptibility or resistance to autoimmune encephalomyelitis in MHC congenic mice is associated with differential production of pro- and anti-inflammatory cytokines.
    Maron R; Hancock WW; Slavin A; Hattori M; Kuchroo V; Weiner HL
    Int Immunol; 1999 Sep; 11(9):1573-80. PubMed ID: 10464178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialomucin CD43 regulates T helper type 17 cell intercellular adhesion molecule 1 dependent adhesion, apical migration and transendothelial migration.
    Velázquez FE; Anastasiou M; Carrillo-Salinas FJ; Ngwenyama N; Salvador AM; Nevers T; Alcaide P
    Immunology; 2019 May; 157(1):52-69. PubMed ID: 30690734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis.
    Ndhlovu LC; Ishii N; Murata K; Sato T; Sugamura K
    J Immunol; 2001 Sep; 167(5):2991-9. PubMed ID: 11509650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional and temporal expression patterns of interleukin-10, interleukin-10 receptor and adhesion molecules in the rat spinal cord during chronic relapsing EAE.
    Ledeboer A; Wierinckx A; Bol JG; Floris S; Renardel de Lavalette C; De Vries HE; van den Berg TK; Dijkstra CD; Tilders FJ; van dam AM
    J Neuroimmunol; 2003 Mar; 136(1-2):94-103. PubMed ID: 12620647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice.
    Calida DM; Constantinescu C; Purev E; Zhang GX; Ventura ES; Lavi E; Rostami A
    J Immunol; 2001 Jan; 166(2):723-6. PubMed ID: 11145641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased severity of myelin oligodendrocyte glycoprotein peptide 33 - 35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene.
    Spahn TW; Issazadah S; Salvin AJ; Weiner HL
    Eur J Immunol; 1999 Dec; 29(12):4060-71. PubMed ID: 10602017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
    Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
    J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
    Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
    Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.